These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18019402)

  • 1. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2007; 21(5):707-13. PubMed ID: 18019402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.
    Lerner AM; Beqaj SH; Deeter RG; Dworkin HJ; Zervos M; Chang CH; Fitzgerald JT; Goldstein J; O'Neill W
    Drugs Today (Barc); 2002 Aug; 38(8):549-61. PubMed ID: 12582420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.
    Lerner AM; Dworkin HJ; Sayyed T; Chang CH; Fitzgerald JT; Beqaj S; Deeter RG; Goldstein J; Gottipolu P; O'Neill W
    In Vivo; 2004; 18(4):417-24. PubMed ID: 15369178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
    Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
    J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A virologic pilot study of valacyclovir in infectious mononucleosis.
    Balfour HH; Hokanson KM; Schacherer RM; Fietzer CM; Schmeling DO; Holman CJ; Vezina HE; Brundage RC
    J Clin Virol; 2007 May; 39(1):16-21. PubMed ID: 17369082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients.
    Ozçay F; Arslan H; Bilezikçi B; Sevmiş S; Moray G; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2878-80. PubMed ID: 19765462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valacyclovir treatment of chronic fatigue in adolescents.
    Henderson TA
    Adv Mind Body Med; 2014; 28(1):4-14. PubMed ID: 24445302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis.
    Vezina HE; Balfour HH; Weller DR; Anderson BJ; Brundage RC
    J Clin Pharmacol; 2010 Jul; 50(7):734-42. PubMed ID: 19897764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.
    Lerner AM; Ariza ME; Williams M; Jason L; Beqaj S; Fitzgerald JT; Lemeshow S; Glaser R
    PLoS One; 2012; 7(11):e47891. PubMed ID: 23155374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir.
    Walling DM; Flaitz CM; Nichols CM
    J Infect Dis; 2003 Sep; 188(6):883-90. PubMed ID: 12964120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
    Fark AR
    J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.
    Montoya JG; Kogelnik AM; Bhangoo M; Lunn MR; Flamand L; Merrihew LE; Watt T; Kubo JT; Paik J; Desai M
    J Med Virol; 2013 Dec; 85(12):2101-9. PubMed ID: 23959519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity.
    Höllsberg P; Kusk M; Bech E; Hansen HJ; Jakobsen J; Haahr S
    Acta Neurol Scand; 2005 Dec; 112(6):395-402. PubMed ID: 16281923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
    Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
    J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I clinical trial of valacyclovir and standard of care cyclophosphamide in children with endemic Burkitt lymphoma in Malawi.
    Olson D; Gulley ML; Tang W; Wokocha C; Mechanic O; Hosseinipour M; Gold SH; Nguluwe N; Mwansambo C; Shores C
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):112-8. PubMed ID: 23260601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
    Kogelnik AM; Loomis K; Hoegh-Petersen M; Rosso F; Hischier C; Montoya JG
    J Clin Virol; 2006 Dec; 37 Suppl 1():S33-8. PubMed ID: 17276366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.
    Hoshino Y; Katano H; Zou P; Hohman P; Marques A; Tyring SK; Follmann D; Cohen JI
    J Virol; 2009 Nov; 83(22):11857-61. PubMed ID: 19740997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of serum IgM IgA and IgG antibodies specific for Epstein-Barr virus as determined by immunoperoxidase assay in the rapid diagnosis of infectious mononucleosis.
    Hadar T; Margalith M; Sagiv E; Sarov B; Sarov I
    Isr J Med Sci; 1995 May; 31(5):280-3. PubMed ID: 7759222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.